| HR | (95% CI) | p value |
---|---|---|---|
Univariate model | |||
 Normal | 1.00 (reference) | – | – |
 Sarcopenia | 1.43 | (0.58–3.52) | 0.439 |
 Obesity | 1.56 | (0.71–3.43) | 0.269 |
 Sarcopenic obesity | 4.50 | (1.93–10.46) | 0.006 |
Multivariate model | |||
 Normal | 1.00 (reference) | – | – |
 Sarcopenia | 1.88 | (0.75–4.74) | 0.179 |
 Obesity | 0.98 | (0.44–2.21) | 0.969 |
 Sarcopenic obesity | 2.63 | (1.10–6.28) | 0.030 |
 HDL cholesterol (mmol/l) | 0.21 | (0.08–0.56) | 0.002 |
 HbA1c (%) | 1.28 | (1.09–1.49) | 0.002 |
 eGFR (ml/min/1.73 m2) | 0.97 | (0.96–0.98) | < 0.001 |
 ACEIs or ARBs | 2.07 | (1.11–3.86) | 0.022 |
 DPP4 inhibitors | 0.46 | (0.23–0.91) | 0.025 |
 History of CVD | 2.85 | (1.57–5.18) | 0.001 |
Gender-adjusted multivariate model | |||
 Normal | 1.00 (reference) | – | – |
 Sarcopenia | 1.46 | (0.57–3.74) | 0.429 |
 Obesity | 0.94 | (0.42–2.10) | 0.870 |
 Sarcopenic obesity | 2.14 | (0.88–5.21) | 0.093 |
 HDL cholesterol (mmol/l) | 0.23 | (0.09–0.62) | 0.003 |
 HbA1c (%) | 1.28 | (1.10–1.49) | 0.001 |
 eGFR (ml/min/1.73 m2) | 0.97 | (0.96–0.96) | < 0.001 |
 ACEIs or ARBs | 2.18 | (1.17–4.10) | 0.014 |
 DPP4 inhibitors | 0.46 | (0.23–0.88) | 0.020 |
 History of CVD | 2.65 | (1.44–4.87) | 0.001 |
 Gender (male = 1) | 1.67 | (0.87–3.20) | 0.126 |